Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain.
Previti S, Ettari R, Calcaterra E, Di Chio C, Ravichandran R, Zimmer C, Hammerschmidt S, Wagner A, Bogacz M, Cosconati S, Schirmeister T, Zappalà M.
Previti S, et al. Among authors: bogacz m.
ACS Med Chem Lett. 2022 Jun 30;13(7):1083-1090. doi: 10.1021/acsmedchemlett.2c00084. eCollection 2022 Jul 14.
ACS Med Chem Lett. 2022.
PMID: 35859868
Free PMC article.